Persist AI Launches Cloud Lab Platform to Revolutionize Pharmaceutical Formulation with AI-Driven Robotics
Persist AI, a leader in AI-driven robotics for pharmaceutical formulation and CMC (Chemistry, Manufacturing, and Controls), today announced the launch of its innovative Cloud Lab platform. Backed by an oversubscribed $12 million Series A round led by Spero Ventures, Persist AI’s platform enables remote development and testing of drug formulations, drastically reducing development time and material consumption compared to traditional methods.
